132 related articles for article (PubMed ID: 7800560)
1. Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis.
Roberts SA; Viana MA; Nazari J; Bauman JL
Pacing Clin Electrophysiol; 1994 Oct; 17(10):1590-602. PubMed ID: 7800560
[TBL] [Abstract][Full Text] [Related]
2. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Feb; 9(2):398-404. PubMed ID: 3805529
[TBL] [Abstract][Full Text] [Related]
3. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
[TBL] [Abstract][Full Text] [Related]
4. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
Reiffel JA
Am J Cardiol; 1996 Aug; 78(4A):34-40. PubMed ID: 8780327
[TBL] [Abstract][Full Text] [Related]
5. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
7. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease.
Nasir N; Doyle TK; Wheeler SH; Pacifico A
Am J Cardiol; 1994 Mar; 73(8):554-8. PubMed ID: 7511872
[TBL] [Abstract][Full Text] [Related]
9. [Predictive factors of induction of ventricular arrhythmia under amiodarone].
Bourret N; Kirkorian G; Chevalier P; Bellon C; Richalet C; Bouchayer D; Bonnefoy E; Touboul P
Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825
[TBL] [Abstract][Full Text] [Related]
10. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
Mason JW
N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
[TBL] [Abstract][Full Text] [Related]
11. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
Sokoloff NM; Spielman SR; Greenspan AM; Rae AP; Brady PM; Kay HR; Horowitz LN
J Am Coll Cardiol; 1986 Apr; 7(4):938-41. PubMed ID: 3958353
[TBL] [Abstract][Full Text] [Related]
12. Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.
Reiffel JA; Reiter MJ; Freedman RA; Mann D; Huang SK; Hahn E; Hartz V; Mason J;
Prog Cardiovasc Dis; 1996; 38(5):359-70. PubMed ID: 8604440
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
Manolis AS; Uricchio F; Estes NA
Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
[TBL] [Abstract][Full Text] [Related]
14. The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone.
Veltri EP; Griffith LS; Platia EV; Guarnieri T; Reid PR
Circulation; 1986 Nov; 74(5):1054-60. PubMed ID: 3769165
[TBL] [Abstract][Full Text] [Related]
15. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
[TBL] [Abstract][Full Text] [Related]
16. Cumulative effects of amiodarone on inducibility of ventricular tachycardia: implications for electrophysiological testing.
Krafchek J; Lin HT; Beckman KJ; Nielsen AP; Magro SA; Hargis J; Wyndham CR
Pacing Clin Electrophysiol; 1988 Apr; 11(4):434-44. PubMed ID: 2453040
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone: value of programmed electrical stimulation and Holter monitoring.
Fisher JD; Kim SG; Waspe LE; Johnston DR
Pacing Clin Electrophysiol; 1986 May; 9(3):422-35. PubMed ID: 2423985
[TBL] [Abstract][Full Text] [Related]
18. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776
[TBL] [Abstract][Full Text] [Related]
19. Significance and incidence of concordance of drug efficacy predictions by Holter monitoring and electrophysiological study in the ESVEM Trial. Electrophysiologic Study Versus Electrocardiographic Monitoring.
Reiter MJ; Mann DE; Reiffel JE; Hahn E; Hartz V
Circulation; 1995 Apr; 91(7):1988-95. PubMed ID: 7895357
[TBL] [Abstract][Full Text] [Related]
20. Prediction of electrophysiologic study results in patients treated with amiodarone.
Ferrick KJ; Singh S; Roth JA; Kim SG; Fisher JD
Am Heart J; 1995 Mar; 129(3):496-501. PubMed ID: 7872178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
